Time course of adiponectin and its relationship to psychological aspects in patients with anorexia nervosa during inpatient treatment
The protein hormone adiponectin promotes metabolic and psychological health. The aim of the study was to track changes in adiponectin levels in response to weight gain and to assess associations between adiponectin and psychological aspects in patients with anorexia nervosa (AN). To investigate if a...
Gespeichert in:
Veröffentlicht in: | PloS one 2017-12, Vol.12 (12), p.e0189500-e0189500 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | e0189500 |
---|---|
container_issue | 12 |
container_start_page | e0189500 |
container_title | PloS one |
container_volume | 12 |
creator | Buckert, Magdalena Stroe-Kunold, Esther Friederich, Hans-Christoph Wesche, Daniela Walter, Christiane Kopf, Stefan Simon, Joe J Herzog, Wolfgang Wild, Beate |
description | The protein hormone adiponectin promotes metabolic and psychological health. The aim of the study was to track changes in adiponectin levels in response to weight gain and to assess associations between adiponectin and psychological aspects in patients with anorexia nervosa (AN).
To investigate if adiponectin levels depend on AN severity, data were assessed from 11 inpatients with a very low body mass index (BMI) and a high chronicity (high severity group; HSS), and nine with less severe symptoms (LSS). During the course of treatment, serum adiponectin concentrations were assessed on a weekly basis along with BMI. Psychological variables (i.e., depression, anxiety, stress, and AN-specific symptoms) were obtained by means of electronic diaries. Longitudinal regressions and correlations were calculated to evaluate the temporal course of adiponectin and its relationship with psychological self-ratings.
At the beginning adiponectin was not increased in HSS patients (p = .56), and only marginally elevated in LSS patients (p = 0.07) compared with controls. In HSS patients, adiponectin increased along with BMI during the first treatment phase (i.e., when the BMI of patients was below 16 kg/m2) and thereafter decreased with further weight gain. In LSS patients, adiponectin was not associated with BMI increase. Furthermore, adiponectin was strongly negatively correlated with psychological self-ratings when the BMI of patients was above 16 kg/m2, i.e., higher levels of adiponectin were related to lower ratings of depression, anxiety, and AN-specific symptoms.
The study connects previous varying results by indicating that the course of adiponectin is dependent on BMI and symptom severity. Similarly, associations of adiponectin and psychological health depended on BMI. |
doi_str_mv | 10.1371/journal.pone.0189500 |
format | Article |
fullrecord | <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_1979768410</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A519675912</galeid><doaj_id>oai_doaj_org_article_fd78b0465a6743c9b0323ee2096d7d68</doaj_id><sourcerecordid>A519675912</sourcerecordid><originalsourceid>FETCH-LOGICAL-c692t-216b7fc55427215aaea4dc03b7cfd85331f04997a809d24401ebab67796c10553</originalsourceid><addsrcrecordid>eNqNk11rFDEUhgdRbK3-A9GAIHqxaz4myeRGKMWPhUJBq7fhTCazm2V2MiaZ2v4A_7fZ7rTsSi9kLnJInvdNzplziuIlwXPCJPmw9mPooZsPvrdzTCrFMX5UHBPF6ExQzB7vxUfFsxjXGHNWCfG0OKKKCiIZOS7-XLqNRSZ7RYt8i6BxW0OTXI-gb5BLEQXbQXK-jys3oOTREG_Mynd-6Qx0COKQ8YiyYMiY7XP826VVlvtgrx2g3oYrHwE1Y3D9MoMTh1KwkDY5el48aaGL9sW0nhQ_Pn-6PPs6O7_4sjg7PZ8ZoWiaUSJq2RrOSyop4QAWysZgVkvTNhVnjLS4VEpChVVDyxITW0MtpFTCEMw5Oyle73yHzkc9VTBqoqSSoioJzsRiRzQe1noIbgPhRntw-nbDh6WGkJzprG4bWdW4FByELJlRNWaUWUuxEo1sRJW9Pk63jfXGNiYnGqA7MD086d1KL_2V5pJVmG4f824yCP7XaGPSGxeN7TrorR937-aUVJJl9M0_6MPZTdQScgKub32-12xN9SknSkiuCM3U_AEqf43dOJO7o3V5_0Dw_kCQmWSv0xLGGPXi-7f_Zy9-HrJv99iVhS6tou_G22Y8BMsdaIKPMdj2vsgE6-203FVDb5tbT9OSZa_2f9C96G482F-LixFo</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1979768410</pqid></control><display><type>article</type><title>Time course of adiponectin and its relationship to psychological aspects in patients with anorexia nervosa during inpatient treatment</title><source>Full-Text Journals in Chemistry (Open access)</source><source>Directory of Open Access Journals</source><source>Public Library of Science</source><source>PubMed Central</source><source>EZB Electronic Journals Library</source><creator>Buckert, Magdalena ; Stroe-Kunold, Esther ; Friederich, Hans-Christoph ; Wesche, Daniela ; Walter, Christiane ; Kopf, Stefan ; Simon, Joe J ; Herzog, Wolfgang ; Wild, Beate</creator><contributor>Stengel, Andreas</contributor><creatorcontrib>Buckert, Magdalena ; Stroe-Kunold, Esther ; Friederich, Hans-Christoph ; Wesche, Daniela ; Walter, Christiane ; Kopf, Stefan ; Simon, Joe J ; Herzog, Wolfgang ; Wild, Beate ; Stengel, Andreas</creatorcontrib><description>The protein hormone adiponectin promotes metabolic and psychological health. The aim of the study was to track changes in adiponectin levels in response to weight gain and to assess associations between adiponectin and psychological aspects in patients with anorexia nervosa (AN).
To investigate if adiponectin levels depend on AN severity, data were assessed from 11 inpatients with a very low body mass index (BMI) and a high chronicity (high severity group; HSS), and nine with less severe symptoms (LSS). During the course of treatment, serum adiponectin concentrations were assessed on a weekly basis along with BMI. Psychological variables (i.e., depression, anxiety, stress, and AN-specific symptoms) were obtained by means of electronic diaries. Longitudinal regressions and correlations were calculated to evaluate the temporal course of adiponectin and its relationship with psychological self-ratings.
At the beginning adiponectin was not increased in HSS patients (p = .56), and only marginally elevated in LSS patients (p = 0.07) compared with controls. In HSS patients, adiponectin increased along with BMI during the first treatment phase (i.e., when the BMI of patients was below 16 kg/m2) and thereafter decreased with further weight gain. In LSS patients, adiponectin was not associated with BMI increase. Furthermore, adiponectin was strongly negatively correlated with psychological self-ratings when the BMI of patients was above 16 kg/m2, i.e., higher levels of adiponectin were related to lower ratings of depression, anxiety, and AN-specific symptoms.
The study connects previous varying results by indicating that the course of adiponectin is dependent on BMI and symptom severity. Similarly, associations of adiponectin and psychological health depended on BMI.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0189500</identifier><identifier>PMID: 29261731</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Adipocytes ; Adiponectin ; Anorexia ; Anorexia nervosa ; Antidepressants ; Anxiety ; Biology and Life Sciences ; Body mass ; Body mass index ; Body size ; Body weight gain ; Care and treatment ; Diaries ; Eating disorders ; Health aspects ; Hospital patients ; Hospitals ; Illnesses ; Internal medicine ; Medicine ; Medicine and Health Sciences ; Mental depression ; Patients ; Peptides ; Physiological aspects ; Protein hormones ; Psychological aspects ; Psychological factors ; Psychosomatic medicine ; Psychotherapy ; Ratings ; Social Sciences ; Studies ; Weight control ; Weight gain</subject><ispartof>PloS one, 2017-12, Vol.12 (12), p.e0189500-e0189500</ispartof><rights>COPYRIGHT 2017 Public Library of Science</rights><rights>2017 Buckert et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2017 Buckert et al 2017 Buckert et al</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c692t-216b7fc55427215aaea4dc03b7cfd85331f04997a809d24401ebab67796c10553</citedby><cites>FETCH-LOGICAL-c692t-216b7fc55427215aaea4dc03b7cfd85331f04997a809d24401ebab67796c10553</cites><orcidid>0000-0002-6126-0442</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5738020/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5738020/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,724,777,781,861,882,2096,2915,23847,27905,27906,53772,53774,79349,79350</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29261731$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Stengel, Andreas</contributor><creatorcontrib>Buckert, Magdalena</creatorcontrib><creatorcontrib>Stroe-Kunold, Esther</creatorcontrib><creatorcontrib>Friederich, Hans-Christoph</creatorcontrib><creatorcontrib>Wesche, Daniela</creatorcontrib><creatorcontrib>Walter, Christiane</creatorcontrib><creatorcontrib>Kopf, Stefan</creatorcontrib><creatorcontrib>Simon, Joe J</creatorcontrib><creatorcontrib>Herzog, Wolfgang</creatorcontrib><creatorcontrib>Wild, Beate</creatorcontrib><title>Time course of adiponectin and its relationship to psychological aspects in patients with anorexia nervosa during inpatient treatment</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>The protein hormone adiponectin promotes metabolic and psychological health. The aim of the study was to track changes in adiponectin levels in response to weight gain and to assess associations between adiponectin and psychological aspects in patients with anorexia nervosa (AN).
To investigate if adiponectin levels depend on AN severity, data were assessed from 11 inpatients with a very low body mass index (BMI) and a high chronicity (high severity group; HSS), and nine with less severe symptoms (LSS). During the course of treatment, serum adiponectin concentrations were assessed on a weekly basis along with BMI. Psychological variables (i.e., depression, anxiety, stress, and AN-specific symptoms) were obtained by means of electronic diaries. Longitudinal regressions and correlations were calculated to evaluate the temporal course of adiponectin and its relationship with psychological self-ratings.
At the beginning adiponectin was not increased in HSS patients (p = .56), and only marginally elevated in LSS patients (p = 0.07) compared with controls. In HSS patients, adiponectin increased along with BMI during the first treatment phase (i.e., when the BMI of patients was below 16 kg/m2) and thereafter decreased with further weight gain. In LSS patients, adiponectin was not associated with BMI increase. Furthermore, adiponectin was strongly negatively correlated with psychological self-ratings when the BMI of patients was above 16 kg/m2, i.e., higher levels of adiponectin were related to lower ratings of depression, anxiety, and AN-specific symptoms.
The study connects previous varying results by indicating that the course of adiponectin is dependent on BMI and symptom severity. Similarly, associations of adiponectin and psychological health depended on BMI.</description><subject>Adipocytes</subject><subject>Adiponectin</subject><subject>Anorexia</subject><subject>Anorexia nervosa</subject><subject>Antidepressants</subject><subject>Anxiety</subject><subject>Biology and Life Sciences</subject><subject>Body mass</subject><subject>Body mass index</subject><subject>Body size</subject><subject>Body weight gain</subject><subject>Care and treatment</subject><subject>Diaries</subject><subject>Eating disorders</subject><subject>Health aspects</subject><subject>Hospital patients</subject><subject>Hospitals</subject><subject>Illnesses</subject><subject>Internal medicine</subject><subject>Medicine</subject><subject>Medicine and Health Sciences</subject><subject>Mental depression</subject><subject>Patients</subject><subject>Peptides</subject><subject>Physiological aspects</subject><subject>Protein hormones</subject><subject>Psychological aspects</subject><subject>Psychological factors</subject><subject>Psychosomatic medicine</subject><subject>Psychotherapy</subject><subject>Ratings</subject><subject>Social Sciences</subject><subject>Studies</subject><subject>Weight control</subject><subject>Weight gain</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>DOA</sourceid><recordid>eNqNk11rFDEUhgdRbK3-A9GAIHqxaz4myeRGKMWPhUJBq7fhTCazm2V2MiaZ2v4A_7fZ7rTsSi9kLnJInvdNzplziuIlwXPCJPmw9mPooZsPvrdzTCrFMX5UHBPF6ExQzB7vxUfFsxjXGHNWCfG0OKKKCiIZOS7-XLqNRSZ7RYt8i6BxW0OTXI-gb5BLEQXbQXK-jys3oOTREG_Mynd-6Qx0COKQ8YiyYMiY7XP826VVlvtgrx2g3oYrHwE1Y3D9MoMTh1KwkDY5el48aaGL9sW0nhQ_Pn-6PPs6O7_4sjg7PZ8ZoWiaUSJq2RrOSyop4QAWysZgVkvTNhVnjLS4VEpChVVDyxITW0MtpFTCEMw5Oyle73yHzkc9VTBqoqSSoioJzsRiRzQe1noIbgPhRntw-nbDh6WGkJzprG4bWdW4FByELJlRNWaUWUuxEo1sRJW9Pk63jfXGNiYnGqA7MD086d1KL_2V5pJVmG4f824yCP7XaGPSGxeN7TrorR937-aUVJJl9M0_6MPZTdQScgKub32-12xN9SknSkiuCM3U_AEqf43dOJO7o3V5_0Dw_kCQmWSv0xLGGPXi-7f_Zy9-HrJv99iVhS6tou_G22Y8BMsdaIKPMdj2vsgE6-203FVDb5tbT9OSZa_2f9C96G482F-LixFo</recordid><startdate>20171220</startdate><enddate>20171220</enddate><creator>Buckert, Magdalena</creator><creator>Stroe-Kunold, Esther</creator><creator>Friederich, Hans-Christoph</creator><creator>Wesche, Daniela</creator><creator>Walter, Christiane</creator><creator>Kopf, Stefan</creator><creator>Simon, Joe J</creator><creator>Herzog, Wolfgang</creator><creator>Wild, Beate</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-6126-0442</orcidid></search><sort><creationdate>20171220</creationdate><title>Time course of adiponectin and its relationship to psychological aspects in patients with anorexia nervosa during inpatient treatment</title><author>Buckert, Magdalena ; Stroe-Kunold, Esther ; Friederich, Hans-Christoph ; Wesche, Daniela ; Walter, Christiane ; Kopf, Stefan ; Simon, Joe J ; Herzog, Wolfgang ; Wild, Beate</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c692t-216b7fc55427215aaea4dc03b7cfd85331f04997a809d24401ebab67796c10553</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Adipocytes</topic><topic>Adiponectin</topic><topic>Anorexia</topic><topic>Anorexia nervosa</topic><topic>Antidepressants</topic><topic>Anxiety</topic><topic>Biology and Life Sciences</topic><topic>Body mass</topic><topic>Body mass index</topic><topic>Body size</topic><topic>Body weight gain</topic><topic>Care and treatment</topic><topic>Diaries</topic><topic>Eating disorders</topic><topic>Health aspects</topic><topic>Hospital patients</topic><topic>Hospitals</topic><topic>Illnesses</topic><topic>Internal medicine</topic><topic>Medicine</topic><topic>Medicine and Health Sciences</topic><topic>Mental depression</topic><topic>Patients</topic><topic>Peptides</topic><topic>Physiological aspects</topic><topic>Protein hormones</topic><topic>Psychological aspects</topic><topic>Psychological factors</topic><topic>Psychosomatic medicine</topic><topic>Psychotherapy</topic><topic>Ratings</topic><topic>Social Sciences</topic><topic>Studies</topic><topic>Weight control</topic><topic>Weight gain</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Buckert, Magdalena</creatorcontrib><creatorcontrib>Stroe-Kunold, Esther</creatorcontrib><creatorcontrib>Friederich, Hans-Christoph</creatorcontrib><creatorcontrib>Wesche, Daniela</creatorcontrib><creatorcontrib>Walter, Christiane</creatorcontrib><creatorcontrib>Kopf, Stefan</creatorcontrib><creatorcontrib>Simon, Joe J</creatorcontrib><creatorcontrib>Herzog, Wolfgang</creatorcontrib><creatorcontrib>Wild, Beate</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale in Context: Opposing Viewpoints</collection><collection>Gale in Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Proquest Nursing & Allied Health Source</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological & Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health & Medical Complete (ProQuest Database)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science & Engineering Collection</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central</collection><collection>Advanced Technologies & Aerospace Collection</collection><collection>ProQuest Agriculture & Environmental Science Database</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Materials Science Database</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Meteorological & Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agriculture Science Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>ProQuest Biological Science Journals</collection><collection>ProQuest Engineering Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest Advanced Technologies & Aerospace Database</collection><collection>ProQuest Advanced Technologies & Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials science collection</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Buckert, Magdalena</au><au>Stroe-Kunold, Esther</au><au>Friederich, Hans-Christoph</au><au>Wesche, Daniela</au><au>Walter, Christiane</au><au>Kopf, Stefan</au><au>Simon, Joe J</au><au>Herzog, Wolfgang</au><au>Wild, Beate</au><au>Stengel, Andreas</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Time course of adiponectin and its relationship to psychological aspects in patients with anorexia nervosa during inpatient treatment</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2017-12-20</date><risdate>2017</risdate><volume>12</volume><issue>12</issue><spage>e0189500</spage><epage>e0189500</epage><pages>e0189500-e0189500</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>The protein hormone adiponectin promotes metabolic and psychological health. The aim of the study was to track changes in adiponectin levels in response to weight gain and to assess associations between adiponectin and psychological aspects in patients with anorexia nervosa (AN).
To investigate if adiponectin levels depend on AN severity, data were assessed from 11 inpatients with a very low body mass index (BMI) and a high chronicity (high severity group; HSS), and nine with less severe symptoms (LSS). During the course of treatment, serum adiponectin concentrations were assessed on a weekly basis along with BMI. Psychological variables (i.e., depression, anxiety, stress, and AN-specific symptoms) were obtained by means of electronic diaries. Longitudinal regressions and correlations were calculated to evaluate the temporal course of adiponectin and its relationship with psychological self-ratings.
At the beginning adiponectin was not increased in HSS patients (p = .56), and only marginally elevated in LSS patients (p = 0.07) compared with controls. In HSS patients, adiponectin increased along with BMI during the first treatment phase (i.e., when the BMI of patients was below 16 kg/m2) and thereafter decreased with further weight gain. In LSS patients, adiponectin was not associated with BMI increase. Furthermore, adiponectin was strongly negatively correlated with psychological self-ratings when the BMI of patients was above 16 kg/m2, i.e., higher levels of adiponectin were related to lower ratings of depression, anxiety, and AN-specific symptoms.
The study connects previous varying results by indicating that the course of adiponectin is dependent on BMI and symptom severity. Similarly, associations of adiponectin and psychological health depended on BMI.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>29261731</pmid><doi>10.1371/journal.pone.0189500</doi><orcidid>https://orcid.org/0000-0002-6126-0442</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1932-6203 |
ispartof | PloS one, 2017-12, Vol.12 (12), p.e0189500-e0189500 |
issn | 1932-6203 1932-6203 |
language | eng |
recordid | cdi_plos_journals_1979768410 |
source | Full-Text Journals in Chemistry (Open access); Directory of Open Access Journals; Public Library of Science; PubMed Central; EZB Electronic Journals Library |
subjects | Adipocytes Adiponectin Anorexia Anorexia nervosa Antidepressants Anxiety Biology and Life Sciences Body mass Body mass index Body size Body weight gain Care and treatment Diaries Eating disorders Health aspects Hospital patients Hospitals Illnesses Internal medicine Medicine Medicine and Health Sciences Mental depression Patients Peptides Physiological aspects Protein hormones Psychological aspects Psychological factors Psychosomatic medicine Psychotherapy Ratings Social Sciences Studies Weight control Weight gain |
title | Time course of adiponectin and its relationship to psychological aspects in patients with anorexia nervosa during inpatient treatment |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T15%3A48%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Time%20course%20of%20adiponectin%20and%20its%20relationship%20to%20psychological%20aspects%20in%20patients%20with%20anorexia%20nervosa%20during%20inpatient%20treatment&rft.jtitle=PloS%20one&rft.au=Buckert,%20Magdalena&rft.date=2017-12-20&rft.volume=12&rft.issue=12&rft.spage=e0189500&rft.epage=e0189500&rft.pages=e0189500-e0189500&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0189500&rft_dat=%3Cgale_plos_%3EA519675912%3C/gale_plos_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1979768410&rft_id=info:pmid/29261731&rft_galeid=A519675912&rft_doaj_id=oai_doaj_org_article_fd78b0465a6743c9b0323ee2096d7d68&rfr_iscdi=true |